Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People with Diabetes

• At: Seville (Spain) (2022)
• Type: Poster
• Poster code: SAP-062
• By: ILOMAKI, Jenni (Monash University, Australia)
• Co-author(s):

  Dr Stephen Wood (Monash University, Parkville, Australia)
  Prof Simon Bell (Monash University, Parkville, Australia)
  Prof Dianna J Magliano
  Prof Jonathan E Shaw
  Prof Matteo Cesari
  Dr Jenni Ilomaki, Senior Lecturer (Monash University, Parkville, Australia)

  
  
• Abstract:

  Background information: Randomised controlled trials and observational studies have found sodium-glucose cotransporter-2 inhibitors (SGLT-2Is) reduce heart failure (HF) hospitalisations and major adverse cardiovascular events (MACE) in general population with type 2 diabetes. However, the effectiveness of SGLT-2Is on cardiovascular outcomes in

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login